CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tobin, S. W.
Right arrow Articles by Arrick, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tobin, S. W.
Right arrow Articles by Arrick, B. A.
Cell Growth & Differentiation Vol. 12, 109-117, February 2001
© 2001 American Association for Cancer Research

Inhibition of Transforming Growth Factor ß Signaling in MCF-7 Cells Results in Resistance to Tumor Necrosis Factor {alpha}: A Role for Bcl-21

Stephen W. Tobin2, Mary Kay Brown, Karen Douville, Drew C. Payne, Alan Eastman and Bradley A. Arrick3

Departments of Medicine [S. W. T., K. D., D. C. P., B. A. A.] and Pharmacology [M. K. B., A. E.], Dartmouth Medical School, Hanover, New Hampshire 03755

Transforming growth factor ß (TGF-ß) is a multifunctional cytokine capable of regulating diverse cellular processes. In this study we investigated the effect of autocrine TGF-ß signaling on tumor necrosis factor (TNF) {alpha}-induced cell death. We abrogated the TGF-ß autocrine loop by overexpression of a truncated TGF-ß type II receptor in MCF-7 breast carcinoma cells and found that this generated resistance to TNF-{alpha}-induced cytotoxicity. To elucidate the molecular basis of the influence of TGF-ß on TNF-{alpha}-induced cytotoxicity, we evaluated the expression levels or activities of proteins involved in TNF-{alpha} signal transduction or the regulation of apoptosis in general in TGF-ß-responsive and TGF-ß-nonresponsive MCF-7 cells. We observed no significant difference in the expression of TNF-{alpha} receptors or the TNF receptor-associated death domain protein. In addition, downstream activation of nuclear factor {kappa}B by TNF-{alpha} was not altered in cells that had lost TGF-ß responsiveness. Analysis of members of the Bcl-2 family of apoptosis-regulatory proteins revealed that Bcl-XL and Bax expression levels were not changed by disruption of TGF-ß signaling. In contrast, the TGF-ß-nonresponsive cells expressed much higher levels of Bcl-2 protein and mRNA than did cells with an intact TGF-ß autocrine loop. Furthermore, restoration of a TGF-ß signal to MCF-7 cells that had spontaneously acquired resistance to TGF-ß caused a reduction in Bcl-2 protein expression. Taken together, our data indicate that loss of autocrine TGF-ß signaling results in enhanced resistance to TNF-{alpha}-mediated cell death and that this is likely to be mediated by derepression of Bcl-2 expression.




This article has been cited by other articles:


Home page
J Biol ChemHome page
N. Fils-Aime, M. Dai, J. Guo, M. El-Mousawi, B. Kahramangil, J.-C. Neel, and J.-J. Lebrun
MicroRNA-584 and the Protein Phosphatase and Actin Regulator 1 (PHACTR1), a New Signaling Route through Which Transforming Growth Factor-{beta} Mediates the Migration and Actin Dynamics of Breast Cancer Cells
J. Biol. Chem., April 26, 2013; 288(17): 11807 - 11823.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
C. N Perera, H. G Chin, N. Duru, and I. G Camarillo
Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression
J. Endocrinol., November 1, 2008; 199(2): 221 - 233.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
D N Danforth Jr
All trans-retinoic acid acts synergistically with hydroxytamoxifen and transforming-growth factor {beta} to stimulate apoptosis in MCF-7 breast cancer cells
J. Endocrinol., November 1, 2004; 183(2): 395 - 404.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. S. Jeruss, C. D. Sturgis, A. W. Rademaker, and T. K. Woodruff
Down-Regulation of Activin, Activin Receptors, and Smads in High-Grade Breast Cancer
Cancer Res., July 1, 2003; 63(13): 3783 - 3790.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 2001 by the American Association of Cancer Research.